Post-approval studies (Phase 4)Study completedNCT05904743
What this trial is testing
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
Who this might be right for
Diabetes Mellitus, Type 1
Mannkind Corporation 141